Stay updated with breaking news from Caredx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of CareDx, Inc (NASDAQ:CDNA – Get Rating) have earned an average rating of “Hold” from the six brokerages that are presently covering the company, MarketBeat reports. Five investment analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average twelve-month target price among brokers […]
CareDx, Inc (NASDAQ:CDNA – Get Rating) has received an average rating of “Hold” from the six brokerages that are covering the firm, MarketBeat.com reports. Five equities research analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company. The average 1-year price target among brokerages that have […]
CareDx Symposium Addresses Barriers in Access to Transplantation ... | May 16, 2023
CareDx, Inc. – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients... | May 10, 2023
CareDx, Inc (NASDAQ:CDNA – Get Rating) insider Reginald Seeto sold 2,819 shares of the stock in a transaction on Tuesday, May 2nd. The shares were sold at an average price of $8.12, for a total value of $22,890.28. Following the completion of the transaction, the insider now owns 534,996 shares of the company’s stock, valued […]